Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication:: A multicenter randomized trial

被引:48
作者
Calvet, X
Ducons, J
Bujanda, L
Bory, F
Montserrat, A
Gisbert, JP
机构
[1] Hosp Sabadell, Digest Dis Unit, Barcelona, Spain
[2] Hosp San Jorge, Gastroenterol Unit, Huesca, Spain
[3] Hosp Donostia, Dept Gastroenterol, San Sebastian, Spain
[4] Hosp Mar, Dept Gastroenterol, Barcelona, Spain
[5] Hosp Princesa, Dept Gastroenterol, Madrid, Spain
关键词
D O I
10.1111/j.1572-0241.2005.50019.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Ten-day triple therapy is somewhat more effective than 7-day treatment for curing Helicobacter pylori infection. Recent studies have suggested that rabeprazole-a proton pump inhibitor with fast onset of acid inhibition-could raise the efficacy of 7-day therapies to the levels obtained with 10-day treatment. OBJECTIVE: To compare the efficacy of 7- and 10-day rabeprazole-based triple therapy for H. pylori eradication. PATIENTS AND METHODS: Four hundred and fifty-eight patients were randomized to 7 or 10 days of triple therapy, including rabeprazole 20 mg, clarithromycin 500 mg, and amoxicillin 1 g, all twice a day. Cure rates were evaluated by urea breath test. RESULTS: Two hundred and thirty-seven patients received 7-day and 221 received 10-day therapy. Groups were comparable in terms of demographic variables. Intention to treat cure rates were 73.8% (95% CI: 67-79%) for 7-day and 79.6% (95%: CI:74-85%) for 10-day therapy (p= 0.09). Per-protocol cure rates were 81.8% (95% CI:76-o86%) and 89.3% (95% CI: 84-93%), p= 0.02, respectively. Cure rates were similar in peptic ulcer patients but in subjects without ulcer they were clearly lower for 7-day therapy: 66%versus 77% by intention to treat (p= 0.08) and 73%versus 91% in the per-protocol analysis (p= 0.004). Side effects and compliance in the two groups were comparable. CONCLUSIONS: Seven- and 10-day triple therapies seem equally efficient in peptic ulcer patients. In contrast, 7-day therapy is significantly less effective in nonulcer dyspepsia patients. Ten-day therapy, therefore, seems preferable when treating nonulcer patients.
引用
收藏
页码:1696 / 1701
页数:6
相关论文
共 50 条
[41]   Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: A randomized comparative trial [J].
Javid G. ;
Zargar S.A. ;
Bhat K. ;
Khan B.A. ;
Yatoo G.N. ;
Gulzar G.M. ;
Shah A.H. ;
Sodhi J.S. ;
Khan M.A. ;
Shoukat A. ;
Saif R.U. .
Indian Journal of Gastroenterology, 2013, 32 (3) :190-194
[42]   TEN-DAYS CONCOMITANT THERAPY IS SUPERIOR TO SEQUENTIAL THERAPY FOR HELICOBACTER PYLORI ERADICATION [J].
Chung, J. ;
Chung, J. ;
Kim, K. ;
Kim, S. ;
Park, D. ;
Kwon, K. ;
Kim, Y. .
HELICOBACTER, 2014, 19 :137-137
[43]   ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION IN PATIENTS WITH DUODENAL ULCERS BASED ON FURAZOLIDONE TRIPLE AND QUADRUPLE THERAPY: A MULTICENTER RANDOMIZED CONTROLLED TRIAL [J].
Lv, N. H. ;
Xie, Y. ;
Guo, X. B. ;
Fan, H. Z. ;
Tang, J. H. ;
Zeng, X. P. ;
Li, X. Q. ;
Len, J. B. ;
Huang, C. B. ;
Xu, N. J. ;
Wang, N. N. ;
Zhou, H. ;
He, X. X. ;
Liu, D. S. ;
Ma, J. H. ;
Lv, Z. F. .
HELICOBACTER, 2011, 16 :87-87
[44]   Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized study [J].
Nasa M. ;
Choksey A. ;
Phadke A. ;
Sawant P. .
Indian Journal of Gastroenterology, 2013, 32 (6) :392-396
[45]   Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial [J].
Hablass, Fahmy H. ;
Lashen, Sameh A. ;
Alsayed, Eman A. .
TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (09) :742-749
[46]   Hybrid versus sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial [J].
Wang, Wei-Chih ;
Lee, Hsi-Chang ;
Chen, Kuan-Yang ;
Tsung-Junglin ;
Lin, Chin-Lin ;
Wang, Chung-Kwe ;
Wu, Deng-Chyang .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 :129-129
[47]   Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori [J].
Chen, Xing Xing ;
Chen, Yu Xin ;
Bi, Han Xin ;
Zhao, Xin ;
Zhang, Li Feng ;
Liu, Jun Ye ;
Shi, Yong Quan .
JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (10) :568-576
[48]   A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori [J].
Fennerty, MB ;
Kovacs, TOG ;
Krause, R ;
Haber, M ;
Weissfeld, A ;
Siepman, N .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (15) :1651-1656
[49]   Antimicrobial sensitivity in a large US multicenter trial of rabeprazole-based triple therapy for H. pylori eradication [J].
Vakil, N ;
Jayanty, V ;
Stanton, D ;
Perdomo, C ;
Hahne, W ;
Barth, J .
GASTROENTEROLOGY, 2002, 122 (04) :A9-A9
[50]   Open-label, multicenter, comparative study of therapy with triple drug trial for eradication of Helicobacter pylori with sodium rabeprazole, ofloxacin and amoxicillin.: Comparative trial of 7 vs. 14 days treatment [J].
Calderón, IE ;
Reed, G ;
Orozco, A ;
Blancas, JM ;
de Ariño, M ;
Tamayo, JL ;
Valdovinos, MA ;
Cobo, C ;
Bosques-Padilla, FJ .
GUT, 2002, 51 :A99-A99